Arca Biopharma sell StockNews.com
Start price
22.12.23
/
50%
€1.51
Target price
22.12.24
-
Performance (%)
116.61%
Price
25.04.24
€3.26
Summary
This prediction is currently active. The price for Arca Biopharma has massively increased, which is bad news for the SELL prediction by StockNews_com. This prediction currently runs until 22.12.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arca Biopharma | - | - |
iShares Core DAX® | 0.000% | -2.064% |
iShares Nasdaq 100 | 0.626% | -2.884% |
iShares Nikkei 225® | 1.568% | -5.892% |
iShares S&P 500 | 0.334% | -2.281% |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ABIO provided by MarketBeat